Advisor Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-19,290
| Closed | -$65K | – | 5367 |
|
|
2018
Q3 | $65K | Buy |
19,290
+6,000
| +45% | +$20.2K | ﹤0.01% | 3088 |
|
|
2018
Q2 | $50K | Sell |
13,290
-2,600
| -16% | -$9.78K | ﹤0.01% | 3114 |
|
|
2018
Q1 | $65K | Sell |
15,890
-1,550
| -9% | -$6.34K | ﹤0.01% | 2878 |
|
|
2017
Q4 | $80K | Buy |
17,440
+9,095
| +109% | +$41.7K | ﹤0.01% | 2747 |
|
|
2017
Q3 | $60K | Sell |
8,345
-1,220
| -13% | -$8.77K | ﹤0.01% | 2812 |
|
|
2017
Q2 | $69K | Sell |
9,565
-38,320
| -80% | -$276K | ﹤0.01% | 2600 |
|
|
2017
Q1 | $295K | Sell |
47,885
-4,505
| -9% | -$27.8K | 0.01% | 1397 |
|
|
2016
Q4 | $308K | Buy |
52,390
+14,335
| +38% | +$84.3K | 0.01% | 1287 |
|
|
2016
Q3 | $203K | Buy |
38,055
+5,225
| +16% | +$27.9K | ﹤0.01% | 1514 |
|
|
2016
Q2 | $216K | Buy |
+32,830
| New | +$216K | 0.01% | 1414 |
|